Lab tests aim to predict best blood cancer drugs
NCT ID NCT04263181
Summary
This study aims to see if testing cancer cells in a lab dish can predict which chemotherapy drugs will work best for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Researchers will collect blood samples from 80 adults before and after they start standard chemotherapy treatment. The goal is to learn if these lab tests can help match patients with the most effective drugs for their specific cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.